Pharvaris NV expected to post a loss of 76 cents a share - Earnings Preview

Pharvaris NV

03/05/2025 24:05

Pharvaris NV PHVS.OQ PHVS.O is expected to show no change in quarterly revenue when it reports  results on May 6 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for Pharvaris NV is for a loss of 76 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Pharvaris NV is $31.00​, above​ its last closing price of $17.85. ​​​

Previous quarterly performance (using preferred earnings measure in euros). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.72
-0.64
Beat
11.2
Sep. 30 2024
-0.62
-0.61
-0.77
Missed
-26.1
Jun. 30 2024
-0.55
-0.55
-0.55
Met
0.5​
Mar. 31 2024
-0.56
-0.56
-0.52
Beat
7.7
​​Dec. 31 2023
-0.37
-0.53
-0.76
Missed
-42.5
Sep. 30 2023
-0.59
-0.60
-0.58
Beat
3.4​
Jun. 30 2023
-0.59
-0.65
-0.63
Beat
3.1
Mar. 31 2023
-0.74
-0.74
-0.67
Beat
9.9

This summary was machine generated May 2 at 23:05 GMT.  All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)